Result of AGM

RNS Number : 9931L

Alliance Pharma PLC

18 May 2022

 

For immediate release

18 May 2022

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Result of AGM

Alliance Pharma plc (AIM: APH), the international healthcare group, announces that, at its Annual General Meeting held earlier today, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.

The votes were as follows:

RESOLUTION		VOTES FOR	%	VOTES AGAINST	%	VOTES TOTAL	% OF ISC VOTED	VOTES WITHHELD
1	Report and Accounts	371,393,469	99.99	30,000	0.01	372,087,366	68.97	663,897
2	Final dividend	372,086,356	100.00	0	0.00	372,087,366	68.97	1,010
3	Re-elect P. Butterfield	371,812,794	99.94	238,118	0.06	372,087,366	68.97	36,454
4	Re-elect D. Cook	304,867,206	91.75	27,427,589	8.25	372,087,366	68.97	39,792,571
5	Re-elect A. Franklin	371,701,797	99.91	346,094	0.09	372,087,366	68.97	39,475
6	Re-elect R. Jones	318,832,469	94.70	17,845,835	5.30	372,087,366	68.97	35,409,062
7	Re-elect J. LeCouilliard	283,289,848	84.14	53,391,477	15.86	372,087,366	68.97	35,406,041
8	Elect K. Neirynck	371,168,677	99.76	882,235	0.24	372,087,366	68.97	36,454
9	Re-appoint Auditor	372,018,741	99.99	38,636	0.01	372,087,366	68.97	29,989
10	Remuneration of Auditor	372,058,198	100.00	2,200	0.00	372,087,366	68.97	26,968
11	Allot shares	314,847,187	84.62	57,236,109	15.38	372,087,366	68.97	4,070
12	Disapply Pre-emption rights	318,400,733	85.57	53,682,363	14.43	372,087,366	68.97	4,270

The number of the Group's shares in issue as at the date of the meeting was 539,461,338 ordinary shares of 1p each.

Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.

Chris Chrysanthou
Head of Legal & Company Secretary
18 May 2022

For further information:

Alliance Pharma plc	+ 44 (0)1249 466966
Cora McCallum, Head of Investor Relations & Corporate Communications	+ 44 (0)1249 705168
[e-mail]
Buchanan	+ 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
[e-mail]
Numis Securities Limited	+ 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield / Duncan Monteith
Corporate Broking: James Black
Investec Bank plc	+ 44 (0)20 7597 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.

Headquartered in the UK, Alliance employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.

For more information on Alliance, please visit our website :  www.alliancepharmaceuticals.com

 

END

 

 

RAGBKFBQQBKDKPD